Semaglutide Weight Loss Dosage Chart and How Titration Works

Semaglutide for weight loss starts at 0.25 mg injected once weekly and increases in steps every four weeks to a maximum of 2.4 mg weekly. That stepwise increase is called titration, and reaching the top dose takes roughly 16 to 20 weeks. The starting dose is deliberately too low to produce much weight loss, because its job is to let your digestive system adapt before the effective doses arrive.

Below we lay out the dosage chart for each form of semaglutide, explain what titration is actually doing inside your body, cover what changes at each step, and address the safety issue that separates prefilled pens from compounded vials.

What Is the Semaglutide Dosage Chart for Weight Loss?

The semaglutide dosage chart for weight loss begins at 0.25 mg once weekly and steps up every four weeks through 0.5 mg, 1.0 mg, and 1.7 mg to a maximum of 2.4 mg weekly. That schedule applies to Wegovy, the version approved specifically for chronic weight management. Ozempic and Rybelsus follow different schedules with different ceilings.

WeekWegovy (weight management)Ozempic (type 2 diabetes)Rybelsus (oral tablet)Weeks 1 to 40.25 mg once weekly0.25 mg once weekly3 mg once dailyWeeks 5 to 80.5 mg once weekly0.5 mg once weekly7 mg once dailyWeeks 9 to 121.0 mg once weekly1.0 mg once weekly14 mg once dailyWeeks 13 to 161.7 mg once weeklyUp to 2.0 mg once weekly14 mg maximumWeek 17 onward2.4 mg once weekly2.0 mg maximum14 mg maximumMaximum dose2.4 mg weekly2.0 mg weekly14 mg dailyTime to maintenanceAbout 16 to 20 weeksAbout 12 to 16 weeksAbout 8 weeks

Sources: U.S. Food and Drug Administration prescribing labels for Wegovy, Ozempic, and Rybelsus.

Rybelsus and Ozempic carry FDA approval for type 2 diabetes rather than for weight management, and providers who prescribe them for weight are doing so off-label. Wegovy holds the approval for chronic weight management in adults with obesity, or in adults with overweight plus a weight-related condition such as high blood pressure or type 2 diabetes. Every plan we build for medical weight loss starts from which product a patient is actually on, because the schedules are not interchangeable.

What Is Titration and Why Does Semaglutide Use It?

Titration is the gradual increase of a medication dose over time until you reach the amount that works for you. Semaglutide uses titration because your digestive system needs weeks to adapt to what the drug does to it.

What the drug does to the digestive system is the part most articles skip. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It slows gastric emptying, meaning food leaves your stomach more slowly, and it modulates insulin and glucagon release after meals while signaling fullness in the brain. Slowed gastric emptying is the mechanism behind reduced appetite, and it is also the mechanism behind the nausea.

Nausea intensity tracks how fast the dose rises rather than how high it is. The receptors and the gut adapt over roughly four weeks at any given level, which is why the interval between steps is four weeks rather than two. Starting a patient at 2.4 mg would produce the same appetite suppression with a level of vomiting and dehydration almost nobody would tolerate. The ramp is not caution for its own sake; it is the only way the effective dose becomes livable. Patients comparing options sometimes ask about peptide options that skip this step, and the honest answer is that any GLP-1 producing real appetite change requires the same adaptation period.

Why Do People Lose Weight So Fast on Semaglutide?

People lose weight quickly on semaglutide because the medication reduces how much they want to eat rather than requiring them to resist wanting to eat. Appetite drops, meals end sooner, and the constant background pull toward food quiets down.

Food noise quieting is what patients describe most often, and it is a pharmacological effect rather than a willpower gain. In the STEP 1 trial published in the New England Journal of Medicine, participants on semaglutide lost an average of 14.9% of body weight over 68 weeks compared with 2.4% on placebo. That figure reflects 68 weeks of treatment, not a fast start.

What Is the Starting Dose of Semaglutide for Weight Loss?

The starting dose of semaglutide for weight loss is 0.25 mg injected once weekly for the first four weeks, and it is intentionally below the level that produces meaningful weight loss. The FDA prescribing label describes this opening dose as a starting dose for treatment initiation rather than a treatment dose.

Treatment effect at 0.25 mg is minimal by design, which surprises people who expect results in month one. The first four weeks buy tolerance. Some patients notice appetite changes at this level, many notice nothing, and neither outcome predicts how well the medication will work at 1.7 or 2.4 mg. Before anyone starts, a full medical evaluation establishes baseline labs, medical history, and whether a GLP-1 is the right tool at all.

How Long Does It Take to Reach the Maintenance Dose?

Reaching the maintenance dose takes roughly 16 to 20 weeks for Wegovy, 12 to 16 weeks for Ozempic, and about 8 weeks for oral Rybelsus. Maintenance dose means the level you stay on long term, which is not always the maximum dose on the label.

The label sequence for injectable semaglutide runs as follows:

1. Begin at 0.25 mg once weekly and hold for four weeks.
2. Increase to 0.5 mg once weekly and hold for four weeks.
3. Increase to 1.0 mg once weekly and hold for four weeks.
4. Increase to 1.7 mg once weekly and hold for four weeks, if prescribed Wegovy.
5. Increase to 2.4 mg once weekly as the Wegovy maintenance dose, or up to 2.0 mg as the Ozempic maximum.
6. Remain at whichever dose delivers results you can tolerate, with periodic review.

Review at each step is where a prescriber decides whether the next increase happens, and this is the part of the chart that misleads people most. We handle those decisions through ongoing medication management rather than by calendar.

Does Everyone Reach the Maximum Dose?

No, not everyone reaches the maximum dose, and stopping at a lower dose is a legitimate endpoint rather than a failed course of treatment. A patient losing weight steadily at 1.0 mg with tolerable side effects has no clinical reason to climb to 2.4 mg.

Climbing when you do not need to simply adds side effect burden. The FDA label also allows for delaying an escalation by four weeks when a patient is not tolerating the current step, and for stepping back down to the previous dose. Neither move restarts the clock or undoes progress.

What Are the Worst Side Effects of Semaglutide?

The worst side effects of semaglutide are the gastrointestinal ones, led by nausea, vomiting, and diarrhea, which are most intense at initiation and during each dose increase. Research published in Frontiers in Public Health and summarized in StatPearls confirms this timing pattern, and also confirms that the symptoms typically diminish as the body adapts.

Adaptation does not happen for everyone. In clinical trials of Wegovy, gastrointestinal effects led between 4% and 17% of participants to stop treatment, and a 2024 analysis in JAMA Network Open found real-world discontinuation running higher than trial rates.

Rates that high are worth knowing before you start. The side effects sort roughly into three tiers:

• Common and usually temporary: nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, heartburn, bloating, belching, and fatigue
• Less common: headache, dizziness, injection site irritation, and low blood sugar in people who also have type 2 diabetes
• Uncommon but serious, requiring prompt contact with your prescriber: pancreatitis, gallbladder problems, kidney problems, worsening diabetic retinopathy in people who already have it, rapid heartbeat, and serious allergic reaction

Serious reactions are rare, but the common ones are common enough that planning for them matters. Slowing down at a dose step, eating smaller and slower meals, avoiding high-fat foods, and increasing fluid intake all help. Anyone weighing this against other approaches may find our discussion of weight loss injections useful for comparison.

What Are the Dangers of Taking Semaglutide?

The dangers of taking semaglutide are concentrated in dosing errors, unsupervised use, and untreated serious side effects rather than in the medication itself when it is prescribed and monitored properly. Semaglutide has a half-life of about one week, which the FDA notes means an excessive dose can require a prolonged period of observation and treatment.

Observation over that long a window is why dose accuracy matters more with this drug than with medications that clear in a day. There is no way to reverse a dose once injected.

What Organ Is Ozempic Hard On?

Ozempic is hardest on the digestive system, with the pancreas, gallbladder, and kidneys carrying the uncommon but serious risks. The FDA label lists pancreatitis, gallbladder disease, and acute kidney injury among the serious adverse reactions, with kidney effects usually secondary to dehydration from prolonged vomiting or diarrhea.

Dehydration is the pathway worth watching, because it is preventable. Persistent vomiting that stops you keeping fluids down is a reason to contact your prescriber the same day, not to wait for the next scheduled visit.

Why Compounded Semaglutide Dosing Works Differently

Compounded semaglutide dosing works differently because it comes in multi-dose vials at concentrations that vary by compounder, so no single milligram-to-unit conversion is correct across products. Prefilled pens deliver a fixed dose. Vials require someone to measure the dose, and that measurement step is where things go wrong.

Things went wrong often enough that on July 26, 2024 the FDA issued a formal alert about dosing errors with compounded injectable semaglutide. The agency reported adverse events from patients and clinicians miscalculating doses when converting milligrams into units or milliliters, with people administering five to twenty times the intended amount. Reported consequences included severe nausea and vomiting, abdominal pain, fainting, dehydration, acute pancreatitis, gallstones, and severe hypoglycemia. Some cases required hospitalization.

Hospitalization from an arithmetic error is a preventable outcome, and the FDA identified specific contributors. Many patients had no prior experience drawing medication from a vial into a syringe. Several were told to use U-100 insulin syringes to measure small volumes. In one reported case a clinician wrote for 20 units instead of 2, and three patients received ten times the intended dose. In another, a physician who takes semaglutide himself miscalculated his own conversion by a factor of ten.

Factors of ten are why we do not publish unit conversion charts. Concentration differs between compounders, and sometimes between products from the same compounder, so a chart that is correct for one vial is dangerous with another. The FDA has separately noted that some compounded products contain salt forms such as semaglutide sodium or semaglutide acetate, which are different active ingredients from the approved drug. If you are prescribed a compounded vial, the only safe dosing instructions are the ones written for your specific concentration by the prescriber who wrote them, confirmed out loud before your first injection. Our Miami Lakes team walks every patient through measurement in person or on camera before they dose at home as part of our weight management program.

Who Should Avoid Semaglutide?

People who should avoid semaglutide include anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, anyone with a history of pancreatitis, and anyone who is pregnant or trying to become pregnant. The FDA label carries a boxed warning for the thyroid tumor risk observed in rodent studies.

Studies in rodents do not automatically translate to people, but the warning stands as an absolute contraindication regardless. Caution also applies to people with severe gastrointestinal disease such as gastroparesis, people with a history of gallbladder disease, and people with existing diabetic retinopathy. A history of eating disorders warrants careful discussion before starting, since appetite suppression interacts poorly with restrictive patterns.

Can a Non-Diabetic Person Take Semaglutide?

Yes, a non-diabetic person can take semaglutide. Wegovy is FDA-approved for chronic weight management in adults without diabetes, provided they meet the weight criteria. Diabetes is not a requirement for the weight management indication.

The indication does require meeting a threshold, which brings up the more common version of this question. People without diabetes who carry weight-related conditions such as high blood pressure, high cholesterol, or prediabetes often qualify at a lower weight threshold than people without those conditions.

Can I Use Semaglutide If I'm Not Overweight?

No, you cannot appropriately use semaglutide if you are not overweight. The FDA-approved criteria require a body mass index of 30 or higher, or a body mass index of 27 or higher with at least one weight-related health condition. Below those thresholds the medication is not indicated.

Thresholds exist because the risk and benefit calculation changes at lower body weights. A person at a healthy weight takes on the full side effect profile and the boxed warning while gaining no established health benefit. Any provider willing to prescribe outside those criteria without a clear clinical rationale is a reason to seek a second opinion.

What Not to Mix With Semaglutide?

What not to mix with semaglutide depends on your full medication list, but the categories requiring adjustment or monitoring are insulin, sulfonylureas, oral medications with narrow absorption windows, and alcohol. Insulin and sulfonylureas combined with semaglutide raise hypoglycemia risk enough that doses often need lowering.

Lowering those doses is a prescriber decision rather than a self-management one. Because semaglutide slows gastric emptying, it can also change how quickly other oral medications absorb, which matters for drugs where timing is tight. Bring a complete list of everything you take, including supplements, to the visit rather than assuming an interaction is too minor to mention.

What Is the Best Time to Take Semaglutide?

The best time to take semaglutide is whichever day and time you will reliably remember, since injectable semaglutide can be taken at any time of day with or without food. What matters is consistency of the day rather than the hour. Many people pick a day anchored to a weekly routine they never miss.

Missing one is still common, and the rules differ by product. For Wegovy, take the missed dose if your next scheduled dose is more than 48 hours away, and skip it if it is closer than that. For Ozempic, take the missed dose within five days, and skip it beyond that. For oral Rybelsus, skip the missed dose and resume the next day. Missing two or more Wegovy doses in a row is a reason to contact your prescriber, who may restart the titration at a lower dose rather than resuming where you left off. These conversations happen easily through virtual follow-ups without waiting for an in-person slot.

How Fast Is Weight Loss on Semaglutide?

Weight loss on semaglutide is gradual rather than fast, with published trial data showing an average of 14.9% of body weight lost over 68 weeks. That average comes from the STEP 1 trial in the New England Journal of Medicine, where the placebo group lost 2.4% over the same period.

The same period covers well over a year, which reframes the expectation most people arrive with. Weight change tends to be minimal during the first eight weeks while doses remain low, becomes noticeable as doses reach 1.0 mg and above, and continues at a slowing rate through the first year. Individual results vary widely around that average, and no honest provider can tell you your number in advance. Setting realistic goals at the start correlates strongly with staying on treatment long enough to see results.

What Causes a Weight Loss Plateau on Semaglutide?

A weight loss plateau on semaglutide is caused by metabolic adaptation, in which a smaller body burns fewer calories at rest, combined with the body reaching a new equilibrium at the current dose. Plateaus are an expected phase of treatment rather than a sign the medication stopped working.

Working differently than expected is not the same as failing. A plateau at month six on a maintenance dose may prompt a review of protein intake, resistance training, sleep, and other medications rather than an immediate dose change. Weight stability after significant loss is itself a clinical outcome worth protecting.

Can Semaglutide Cause Anxiety or Depression?

Semaglutide can be associated with mood changes in some people, though the evidence for semaglutide directly causing anxiety or depression is limited and mixed. Mood symptoms during treatment more often trace to indirect pathways than to the drug acting on mood circuitry.

Indirect pathways are worth naming specifically. Sharply reduced food intake can produce low blood sugar, dehydration, and nutrient gaps, all of which affect mood and energy. Ongoing nausea wears people down. Rapid changes in body size can unsettle self-image in ways patients do not anticipate. For anyone with an existing mood or anxiety condition, starting a GLP-1 is a reason to keep psychiatric follow-up closer rather than looser during the titration months.

Closer follow-up is straightforward when psychiatric and primary care sit in the same practice, which is how we handle it. If mood shifts during treatment, that belongs in the conversation with your prescriber rather than being absorbed as a cost of losing weight. Metabolic and endocrine factors also run both directions here, and our discussion of hormones and weight covers some of that overlap.

Why Do I Feel Happier on Semaglutide?

Some people feel happier on semaglutide because the constant mental preoccupation with food quiets down, freeing attention and reducing a source of daily self-criticism. Patients describe this as food noise going away, and the relief of it is real.

Real relief also comes from progress after a long history of unsuccessful attempts, from improved energy, and from better sleep as weight comes down. None of these require the drug to be acting as an antidepressant to explain the change.

How Long Can You Stay on Semaglutide?

You can stay on semaglutide indefinitely, and the medication is designed for long-term use in the same way blood pressure medication is. There is no built-in stopping point once you reach a maintenance dose that works.

Working long term requires periodic reassessment rather than a set-and-forget prescription. Labs, blood pressure, weight trend, side effect burden, and any new medications all factor into whether the current dose remains right. That reassessment is a standing part of the GLP-1 support we provide to patients in Miami Lakes rather than an occasional check.

Why Is Ozempic a Lifetime Drug?

Ozempic functions as a long-term medication because it treats an ongoing metabolic condition rather than curing it, so its effects last only as long as it is taken. Obesity behaves as a chronic condition with a strong biological drive toward weight regain.

Regain after stopping is the direct consequence of that biology, not a personal failure. The same logic applies to statins and blood pressure medication, where nobody expects the benefit to persist after discontinuation.

What Happens If You Stop Semaglutide?

If you stop semaglutide, appetite returns to its previous level within weeks and most people regain a substantial portion of the weight they lost. Gastric emptying returns to normal speed, satiety signaling drops back to baseline, and the food noise comes back.

Coming back is well documented in follow-up research on GLP-1 discontinuation, which consistently shows weight trending upward after the medication stops. This is why the decision to stop deserves the same planning as the decision to start, including whether a lower maintenance dose might be workable instead.

Can Semaglutide Cause Weight Gain After Stopping?

Semaglutide does not cause weight gain after stopping, but weight regain after stopping is common because the underlying appetite regulation returns to how it worked before treatment. The medication was suppressing a drive that never disappeared.

Disappearance was never the mechanism. Nothing about having taken semaglutide leaves you worse off than your pre-treatment baseline, and the regain reflects the original condition reasserting itself rather than a rebound the drug created.

What Are the Withdrawal Symptoms of Semaglutide?

Semaglutide has no withdrawal syndrome. It is not habit-forming and stopping it does not produce physical withdrawal symptoms. What people describe as withdrawal is the return of appetite and, in people with type 2 diabetes, a rise in blood sugar that needs monitoring.

Monitoring matters more than tapering here. Because the half-life is about a week, the medication clears gradually on its own over four to five weeks, so no taper schedule is required. Anyone with diabetes stopping semaglutide needs a plan for glucose control before the last dose.

Why Are People Stopping Ozempic?

People are stopping Ozempic mainly because of side effects, cost and coverage problems, supply access, and expectations that did not match the pace of results. The 2024 JAMA Network Open analysis found real-world discontinuation exceeding what clinical trials predicted.

Predicted rates run lower than reality partly because trial participants receive close support that most patients never get. Many discontinuations are avoidable with a slower titration, better management of nausea, or a temporary step back to a lower dose. Stopping because month two produced no visible change is the most preventable reason of all, given that the first eight weeks are titration rather than treatment.

Frequently Asked Questions

Is Semaglutide Good for Weight Loss?

Semaglutide is effective for weight loss in people who meet the clinical criteria for it. The STEP 1 trial found an average loss of 14.9% of body weight over 68 weeks compared with 2.4% on placebo. Whether it is a good choice for a specific person depends on medical history, other medications, tolerance for gastrointestinal side effects, and willingness to treat it as long-term care.

Has Anyone Kept Weight Off After Semaglutide?

Some people maintain part of their loss after stopping semaglutide, but published follow-up data shows most regain a substantial portion. The people who hold results best tend to have built sustained changes in eating patterns, protein intake, and resistance training during treatment rather than relying on appetite suppression alone.

What Is Compounded Semaglutide?

Compounded semaglutide is semaglutide prepared by a compounding pharmacy rather than manufactured as an FDA-approved product. Compounded drugs do not undergo FDA review for safety, effectiveness, or manufacturing quality. Concentrations vary between compounders, and the FDA has noted that some compounded products use salt forms that are different active ingredients from the approved drug.

How Do You Qualify for Semaglutide?

You qualify for semaglutide for weight management with a body mass index of 30 or higher, or 27 or higher alongside at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. Qualification also requires review of contraindications, which is why a first visit includes history, medication reconciliation, and routine lab work.

Semaglutide vs Tirzepatide for Weight Loss: What Is the Difference?

The difference between semaglutide and tirzepatide is that semaglutide targets one receptor, GLP-1, while tirzepatide targets two, GLP-1 and GIP. Both follow stepwise titration schedules with four-week intervals, and both produce gastrointestinal side effects concentrated at dose increases. Which one suits a given patient depends on medical history, tolerance, and coverage rather than on one being universally superior.

How Does Semaglutide Work for Weight Loss?

Semaglutide works for weight loss by slowing how quickly food leaves the stomach, regulating insulin and glucagon release after meals, and signaling fullness to the brain. Together these effects lower appetite and reduce cravings. The slowed gastric emptying that produces the appetite effect is also what produces the nausea, which is why the dose has to climb gradually.

Putting It All Together

The semaglutide dosage chart is straightforward on paper: 0.25 mg weekly to start, a step up every four weeks, and a maximum of 2.4 mg for Wegovy or 2.0 mg for Ozempic. What the chart does not show is that escalation is a clinical decision rather than a calendar event, that stopping at a lower dose is a legitimate outcome, that the first eight weeks are adaptation rather than treatment, and that compounded vials introduce a measurement step where five-to-twenty-fold overdoses have sent people to the hospital. Those four points determine whether the schedule works for you.

If you are considering a GLP-1, already on one and unsure whether your dose is right, or trying to sort out which product you are actually taking, that is worth a conversation with a prescriber who will review your full history first. At South Florida Med Group, we treat weight as a medical condition with a long arc rather than a short program.

Ongoing monitoring is what makes the long arc work, and we are glad to talk it through whenever you want to get started.

‍